Literature DB >> 17587483

NOX5 is expressed at the plasma membrane and generates superoxide in response to protein kinase C activation.

Lena Serrander1, Vincent Jaquet, Karen Bedard, Olivier Plastre, Oliver Hartley, Serge Arnaudeau, Nicolas Demaurex, Werner Schlegel, Karl-Heinz Krause.   

Abstract

NOX5 is a ROS-generating NADPH oxidase which contains an N-terminal EF-hand region and can be activated by cytosolic Ca(2+) elevations. However the C-terminal region of NOX5 also contains putative phosphorylation sites. In this study we used HEK cells stably expressing NOX5 to analyze the size and subcellular localization of the NOX5 protein, its mechanisms of activation, and the characteristics of the ROS released. We demonstrate that NOX5 can be activated both by the protein kinase C activating phorbol esther PMA and by the Ca(2+) ionophore ionomycin. The PMA- but not the ionomycin-dependent activation can be inhibited by protein kinase C inhibitors. NOX5 activity is inhibited by submicromolar concentrations of diphenyl iodonium (DPI), but not by apocynin. Western blot analysis showed a lower ( approximately 70 kDa) than expected (82 kDa) molecular mass. Two arguments suggest that NOX5 is at least partially expressed on the plasma membrane: (i) the membrane-impermeant superoxide was readily detected by extracellular probes, and (ii) immunofluorescent labeling of NOX5 detected a fraction of the NOX5 protein at the plasma membrane. In summary, we demonstrate that NOX5 can be found intracellularly and at the cell surface. We also describe that it can be activated through protein kinase C, in addition to its Ca(2+) activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17587483     DOI: 10.1016/j.biochi.2007.05.004

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  59 in total

1.  Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells.

Authors:  Augusto C Montezano; Dylan Burger; Tamara M Paravicini; Andreia Z Chignalia; Hiba Yusuf; Mahmoud Almasri; Ying He; Glaucia E Callera; Gang He; Karl-Heinz Krause; David Lambeth; Mark T Quinn; Rhian M Touyz
Journal:  Circ Res       Date:  2010-03-25       Impact factor: 17.367

2.  Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse.

Authors:  Jay C Jha; Aozhi Dai; Chet E Holterman; Mark E Cooper; Rhian M Touyz; Chris R Kennedy; Karin A M Jandeleit-Dahm
Journal:  Diabetologia       Date:  2019-06-20       Impact factor: 10.122

Review 3.  Nox5 and the regulation of cellular function.

Authors:  David J R Fulton
Journal:  Antioxid Redox Signal       Date:  2009-10       Impact factor: 8.401

Review 4.  Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.

Authors:  Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Circ Res       Date:  2012-05-11       Impact factor: 17.367

Review 5.  Nox enzymes in immune cells.

Authors:  William M Nauseef
Journal:  Semin Immunopathol       Date:  2008-05-01       Impact factor: 9.623

6.  Nox5 forms a functional oligomer mediated by self-association of its dehydrogenase domain.

Authors:  Tsukasa Kawahara; Heather M Jackson; Susan M E Smith; Paul D Simpson; J David Lambeth
Journal:  Biochemistry       Date:  2011-03-04       Impact factor: 3.162

Review 7.  Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling.

Authors:  Imad Al Ghouleh; Nicholas K H Khoo; Ulla G Knaus; Kathy K Griendling; Rhian M Touyz; Victor J Thannickal; Aaron Barchowsky; William M Nauseef; Eric E Kelley; Phillip M Bauer; Victor Darley-Usmar; Sruti Shiva; Eugenia Cifuentes-Pagano; Bruce A Freeman; Mark T Gladwin; Patrick J Pagano
Journal:  Free Radic Biol Med       Date:  2011-06-14       Impact factor: 7.376

8.  Bridged tetrahydroisoquinolines as selective NADPH oxidase 2 (Nox2) inhibitors.

Authors:  Eugenia Cifuentes-Pagano; Jaideep Saha; Gábor Csányi; Imad Al Ghouleh; Sanghamitra Sahoo; Andrés Rodríguez; Peter Wipf; Patrick J Pagano; Erin M Skoda
Journal:  Medchemcomm       Date:  2013-07       Impact factor: 3.597

9.  NADPH oxidase expression and production of superoxide by human corneal stromal cells.

Authors:  William J O'Brien; Tom Heimann; Farhan Rizvi
Journal:  Mol Vis       Date:  2009-12-03       Impact factor: 2.367

Review 10.  Nox proteins in signal transduction.

Authors:  David I Brown; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2009-07-21       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.